Tirzepatide 30mg
Tirzepatide 30mg – Premium Research Peptide
Tirzepatide is a first-in-class dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its unique dual incretin mechanism has made it a major focus of research into glucose regulation, weight management, and metabolic health. This 30mg vial provides a larger format for laboratories conducting extended or high-dosage studies.
Key Benefits for Research
- High-purity 30mg vial of Tirzepatide for advanced research needs
- Dual GIP/GLP-1 receptor activity for metabolic studies
- Studied for glucose regulation, appetite control, and weight loss
- Manufactured in the USA with rigorous quality standards
About Tirzepatide
Tirzepatide acts on two key incretin pathways, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and regulating appetite. Research continues to explore its applications for type 2 diabetes, obesity, and metabolic syndrome, with promising results in preclinical and clinical studies.
Why Choose Our Tirzepatide 30mg?
Our Tirzepatide 30mg is produced using advanced peptide synthesis to guarantee exceptional purity, stability, and reproducibility. Each vial undergoes strict laboratory testing, making it a dependable choice for metabolic and endocrine research requiring larger doses.
Usage & Storage
- For laboratory research use only
- Store at -20°C for long-term stability
- Reconstitute with sterile solution prior to use
Product Details
- CAS Number: 2023788-19-2
- Molecular Formula: C225H348N48O68
- Molecular Weight: ~4,814 g/mol
- Appearance: White lyophilized powder







Reviews
There are no reviews yet.